About – Douglas Berger Psychiatrist Tokyo


Dr. Douglas Berger, M.D., Ph.D., Meguro Counseling Center Director

Dr. Berger came to Japan as a medical exchange student and psychiatric researcher at the Tokai University School of Medicine on a research fellowship from the Matsumae International Foundation. He later returned to Japan to do further psychiatric research at the Tokyo University Department of Psychosomatic Medicine and the Tokyo Institute of Psychiatry. Dr. Berger speaks native-level Japanese and regularly conducts psychotherapy for mixed-cultural couples as well as the local Japanese community. This page lists Dr. Berger’s research activity, and this page is an archive of community education articles for the Tokyo Families Magazine written by Dr. Berger. Dr. Berger also works extensively with children as Director of the Tokyo Child & Adolescent Counseling Service. Dr. Berger is a legal permanent resident of Japan.

Douglas Berger is a now a fully bilingual American board certified psychiatrist, is the Director of the Tokyo Meguro Counseling Center. Douglas Berger is a M.D., and a Ph.D. Dr.  Berger is a graduate of New York Medical College where he completed a 4-year residency program in psychiatry. He then finished a fellowship in Psychosomatic Medicine at the Albert Einstein College of Medicine. Now based in Tokyo, he had served on the Faculty of the Albert Einstein College of Medicine Department of Psychiatry in New York as an Assistant Professor of Psychiatry and licensed practicing U.S. physician. Dr. Berger’s Japanese qualifications include a Ph.D. from the University of Tokyo School of Medicine received for psychiatric research done while at the Tokyo University Department of Psychosomatic Medicine.

Credential Verifications

Dr. Berger’s medical degree is from the United States, he is well-versed in the use of psychiatric medication and can guide the use of psychiatric medications integrated with psychotherapy through the physicians affiliated with his counseling practice (he does not directly practice medical care in Japan). Further information on Dr. Berger can be seen on his personal home page.

Publications by Dr. Douglas Berger, psychiatrist in Tokyo

Berger D: DOUBLE BLINDING REQUIREMENT FOR VALIDITY CLAIMS IN COGNITIVE-BEHAVIORAL THERAPY INTERVENTION TRIALS FOR MAJOR DEPRESSIVE DISORDER. Analysis of Hollon S, et al., Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial, F1000Research 2015, 4:639 (doi: 10.12688/f1000research.6954.1). U.S. National Library of Medicine version.

Berger D: DOUBLE-BLINDING AND BIAS IN MEDICATION AND COGNITIVE-BEHAVIORAL THERAPY TRIALS FOR MAJOR DEPRESSIVE DISORDER, F1000Research 2016, 4:638 (doi: 10.12688/f1000research.6953.2). U.S. National Library of Medicine version.

Articles by Douglas Berger, M.D., Ph.D. for Tokyo Families magazine.

Click here to see a full list of articles.

For more information on Dr. Doug Berger, read some of the articles here.

To contact Douglas Berger psychiatrist Tokyo and set up an appointment, click here.

Anxiety the chameleon: sleep disturbance, nail biting, intrusive thoughts, can’t make decisions, etc. First nail-down the diagnosis! Us: https://t.co/W6SS4mCEuf, https://t.co/urVpIy8ewg

Many people are controlling in style. They don’t realize they get aggravated when others stand up for themselves, and they get upset trying to control others. Us: https://t.co/W6SS4mDcjN, https://t.co/urVpIy8MlO

Many persons stable on a medication regimen want to change to something else they hear about or friends tell them. Caution is the word! Us: https://t.co/W6SS4mCEuf, https://t.co/urVpIy8ewg

Why do some people continue to subject themselves to abuse both physically and psychologically? It’s complex but often results from a “comfort” to have distress to fight against. Us: https://t.co/W6SS4mUflN, https://t.co/urVpIxQD7G

Chronic mild depression that is up and down mixed with actual social stress often results in confusion in the person as to whether they are really ill or if it’s situational. These persons can go for decades without real help. Us: https://t.co/W6SS4mCEuf, https://t.co/urVpIy8ewg

Load More...

Lately everybody and their grandma have become proud armchair epidemiologists, virologists, maskologists, and vaccinologists. If I disagree with something and remind them, “actually I have a license to practice medicine”, sparks can fly. Very disconcerting.

If a clinical trial endpoint is subjective like depression, there must be a blind placebo control group. If you will blast a building and want to measure the damage, you don't need a placebo control group because this is objective. Clearly, a no-blast will show no damage.

Clinical trials require that the data collection is going to be exact. Many a trial fails when the data is audited. This is called Good Clinical Practice. #clinicaltrials

Poor sleep and meds: many people give-up quickly when there is plenty of chance to adjust dose, type, and regimen where a rotation of drug-type is often effective. #insomnia

Medication doses and formulations can differ from country to country. Creative adjustments of dose breaking pills or emptying capsules and close monitoring until the patient moves into a new stable state are good ways to handle this issue. #drugformulation #medications

Load More...